Showing results (451-460 of 466) with videos related to
Sort By:
Pageof 47
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 18, 2019
Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virusTheresa Enkirch, Ettore Severi, Harry Vennema, et al.Physics of Plasmas|June 28, 2017
Laser-plasmas in the relativistic-transparency regime: Science and applicationsJuan C Fernández, D Cort Gautier, Chengkung Huang, et al.Annals of the Rheumatic Diseases|April 11, 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyMuriel Elhai, Marouane Boubaya, Oliver Distler, et al.Annals of the Rheumatic Diseases|August 17, 2012
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication studyLara Bossini-Castillo, Jose Ezequiel Martin, Jasper Broen, et al.Rheumatology (Oxford, England)|August 31, 2011
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European populationLara Bossini-Castillo, Carmen P Simeon, Lorenzo Beretta, et al.Nature Communications|November 2, 2019
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathwaysElena López-Isac, Marialbert Acosta-Herrera, Martin Kerick, et al.Annals of the Rheumatic Diseases|November 23, 2012
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibilityLina-Marcela Diaz-Gallo, Carmen P Simeon, Jasper C Broen, et al.Journal of Internal Medicine|February 15, 2019
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trialG L Goll, K K Jørgensen, J Sexton, et al.Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.Pageof 47